enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Apremilast - Wikipedia

   en.wikipedia.org/wiki/Apremilast

   Apremilast, sold under the brand name Otezla among others, is a medication for the treatment of certain types of psoriasis and psoriatic arthritis. [4] The drug acts as a selective inhibitor of the enzyme phosphodiesterase 4 (PDE4). [ 4 ]

3. Race to Effective Psoriasis Treatment: Can-Fite's ... - AOL

   www.aol.com/news/race-effective-psoriasis...

   Amgen Inc. (NASDAQ: AMGN) recently announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application (sNDA) for Otezla for the treatment of ...

4. PDE4 inhibitor - Wikipedia

   en.wikipedia.org/wiki/PDE4_inhibitor

   Crisaborole (AN2728), a boron-containing drug for the topical treatment of psoriasis and atopic dermatitis. [24] [25] It was approved by the FDA on December 14, 2016 under the brand name Eucrisa for the treatment of mild-to-moderate atopic dermatitis (eczema) in patients 2 years of age and older. [26] Caffeine is a weak, non-selective PDE ...

5. Psoriatic arthritis - Wikipedia

   en.wikipedia.org/wiki/Psoriatic_arthritis

   Psoriatic arthritis (PsA) is a long-term inflammatory arthritis that occurs in people affected by the autoimmune disease psoriasis. [1] [2] The classic features of psoriatic arthritis include dactylitis (sausage-like appearance), skin lesions, and nail lesions. [3]

6. Which Psoriasis Treatment is Right for You? - AOL

   www.aol.com/lifestyle/psoriasis-treatment...

   For premium support please call: 800-290-4726 more ways to reach us

7. Bristol Myers' Psoriasis Med Deucravacitinib Superior To ...

   www.aol.com/news/bristol-myers-psoriasis-med...

   Bristol-Myers Squibb Co (NYSE: BMY) has announced new data from its two Phase 3 trials POETYK PSO-1 and POETYK PSO-2 for deucravacitinib, its oral, selective TYK2 inhibitor for moderate to severe ...